Medicina Intensiva

[Validation of the P/FPe index in a cohort of patients with ARDS secondary to SARS-CoV-2]
González-Castro A, Martos Benítez FD, Fernández-Rodríguez A, Orama-Requejo V, Ferrero-Franco R and Peñasco Y
Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
Ioan AM, Gonzalez-Lorenzo O, Kallmeyer Mayor A, Pérez-Calvo C and Santos A
[A need for post-intensive care follow-up training]
Tejero-Aranguren J, Poyatos Aguilera E, Colmenero M and García Del Moral R
[ spp ventriculitis: Uncommon cause of altered level of consciousness]
Álvarez Méndez A, Castro Bournissen L and López Gil MJ
[Clinical experience in prophylactic enoxaparin dosage adjustment guided by anti-Xa factor levels in critical care patients with COVID-19 pneumonia: Observational study]
Del Carmen Bermúdez-Ruiz M, Vilar Sánchez I, Aparicio Pérez C, Carmona Flores R, Rodríguez-Gómez J and de la Fuente-Martos C
[Transfer support and coordination of critical patients during the COVID-19 pandemic by a regional command center]
Trenado J, Solà S, Campos O, Morales JA, Azeli Y and Jiménez X
[Multidisciplinary approach to the sequelae of severe COVID-19 pneumonia at discharge from Critical Care: are there differences depending on the respiratory therapy used?]
Rubio Sanchiz O
Ultrasound assessment of pulmonary abscess
Mongodi S, Bonaiti S and Mojoli F
[Multidisciplinary approach of the sequelae one month after hospital discharge in patients with severe bilateral COVID-19 pneumonia, are there differences depending on the respiratory therapy used during admission to intensive care?]
Sánchez-García AM, Martínez-López P, Gómez-González AM, Rodriguez-Capitán J, Jiménez-López RJ, García Almeida JM, Avanesi-Molina E, Zamboschi N, Rueda-Molina C, Doncel-Abad V, Molina-Ramos AI, Cabrera-César E, Ben-Abdellatif I, Gordillo-Resina M, Pérez-Mesa E, Nieto-González M, Nuevo-Ortega P, Reina-Artacho C, Sánchez Fernández PL, Jiménez-Navarro MF and Estecha-Foncea MA
To describe the sequelae one month after hospital discharge in patients who required admission to intensive care for severe COVID-19 pneumonia and to analyze the differences between those who received therapy exclusively with high-flow oxygen therapy compared to those who required invasive mechanical ventilation.
[Results of the use of plasma from convalescent patients of COVID 19 in critically ill patients]
Astola Hidalgo I, Fernández Rodríguez A, Martínez Revuelta E, Martínez Revuelta M, Ojea AM, Herrero Puente P and Escudero Augusto D
[Macklin effect as an early radiological predictor of barotrauma in ARDS COVID-19 patients in invasive mechanical ventilation]
Casadiego Monachello FJ, de la Torre Terron MC, Mendez Barraza JA and Casals Vila S
[COVID-19-associated lung weakness (CALW): Systematic review and meta-analysis]
Redruello-Guerrero P, Ruiz-Del-Pino M, Jiménez-Gutiérrez C, Jiménez-Gutiérrez P, Carrascos-Cáliz A, Romero-Linares A, Láinez Ramos-Bossini AJ, Rivera-Izquierdo M and Cárdenas-Cruz A
To assess mortality and different clinical factors derived from the development of atraumatic pneumothorax (PNX) and/or pneumomediastinum (PNMD) in critically ill patients as a consequence of COVID-19-associated lung weakness (CALW).
[Orotracheal intubation in the COVID patient; a practice not exempt from risk]
Trenado-Alvarez J
Massive hemoptysis due to -related pulmonary artery pseudoaneurysm in a patient with COVID-19 pneumonia
Baeza I, Romera I and Fortuño JR
[The Bayes factor in the analysis of mechanical power in patients with severe respiratory failure due to SARS-CoV-2]
González-Castro A, Modesto I Alapont V, Cuenca Fito E, Peñasco Y, Escudero Acha P, Huertas Martín C and Rodríguez Borregán JC
To specify the degree of probative force of the statistical hypotheses in relation to mortality at 28 days and the threshold value of 17 J/min mechanical power (MP) in patients with respiratory failure secondary to SARS-CoV-2.
Airways management in SARS-COV-2 acute respiratory failure: A prospective observational multi-center study
Cattin L, Ferrari F, Mongodi S, Pariani E, Bettini G, Daverio F, Donadello K, Polati E, Mojoli F, Danzi V and De Rosa S
Few studies have reported the implications and adverse events of performing endotracheal intubation for critically ill COVID-19 patients admitted to intensive care units. The aim of the present study was to determine the adverse events related to tracheal intubation in COVID-19 patients, defined as the onset of hemodynamic instability, severe hypoxemia, and cardiac arrest.
[Effect of duration of prone position in ARDS patients during SARS-CoV-2 pandemic]
de Miguel-Balsa E, Blasco-Ruso T, Gómez-Medrano N, Mirabet-Guijarro M, Martínez-Pérez A and Alcalá-López A
To describe the characteristics of patients with acute respiratory distress syndrome due to bilateral COVID-19 pneumonia on invasive mechanical ventilation (IMV) and analyze the effect of prolonged prone decubitus > 24 h (PPD) compared to prone decubitus < 24 h (PD).
[Early lung autopsy in deceased patients with acute respiratory distress syndrome due to infection by SARS-CoV-2]
Rodriguez F, Nin N, Fajardo A, Aunchayna M, Guerendiaín R and Hurtado J
Prone position improves ventilation-perfusion mismatch in patients with severe acute respiratory distress syndrome
Bachmann MC, Basoalto R, Díaz O, Bruhn A, Bugedo G and Retamal J
Intermediate tidal volume is an acceptable option for ventilated patients with acute respiratory distress syndrome
Wu SH, Kor CT, Li CY and Hsiao YC
Evidence only proves low surpasses high tidal volume ( ) for acute respiratory distress syndrome (ARDS). Intermediate is a common setting for ARDS patients and has been demonstrated as effective as low in non-ARDS patients. The effectiveness of intermediate in ARDS has not been studied and is the objective of this study.
[Post-intensive care syndrome one month after hospital discharge of critical patients surviving COVID 19.]
Iribarren-Diarasarri S, Bermúdez-Ampudia C, Barreira-Mendez R, Vallejo-Delacueva A, Bediaga-Díazdecerio I, Martinez-Alútiz S, Ruilope-Alvaro L, Vinuesa-Lozano C, Aretxabala-Cortajarena N, San Sebastián-Hurtado A, Martín-Martínez M and Arce-Gómez I
incidence of post-intensive care syndrome at one month after hospital discharge in surviving critically ill COVID 19 patients and to identify associated factors.